Alyeska Investment Group
CHRS icon

Alyeska Investment Group’s Coherus Oncology CHRS Stock Holding History

Alyeska Investment Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
2018
Q3 		$1.65M Sell
2018
Q2 		$5.58M Sell
2018
Q1 		$5.04M Sell
2017
Q4 		$4.26M Sell
2017
Q3 		$7.47M Sell
2017
Q2 		$8.41M Buy
2017
Q1 		$9.52M Buy
2015
Q1 		– Sell
2014
Q4 		$558K Buy